XNAS: RNAZ
TransCode Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Pha...
Read More
4.00
-0.25
(-5.88%)
7,755.3
XNAS Volume
XNAS 06 Aug, 2026 12:30 PM (EDT)
Board Meeting
The next board meeting for TransCode Therapeutics Inc is on 14 Aug 2026 for the purpose of TransCode Therapeutics Inc Second Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
TransCode Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..